Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
END-AFLD: Low-dose colchicine for prevention of atrial fibrillation after cardiac surgery
NCT03015831Phase 3Terminated
- Sponsor
- Jordan Collaborating Cardiology Group
- Start
- Oct 2017
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Colchicine with Placebo (2 arms). Primary endpoint: Atrial Fibrillation at 1 week. Started Oct 2017; status: terminated.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03015831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015831.